CROSS COUNTRY HEALTHCARE INC(CCRN)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,612 of 2,961 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
CCRN Stock Analysis & AI Quality Score
Data updated 2026-09-09AI stock analysis and institutional research for CROSS COUNTRY HEALTHCARE INC (CCRN), a Industrials sector company. 13F Pro's AI-powered ranking engine scores CCRN at 26.6/100 on a 32-signal composite quality model, placing it at rank #2,612 of 2,961 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (2.7) and balance sheet strength (11.4), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), CROSS COUNTRY HEALTHCARE INC reports quarterly revenue of $241.1M, net income of $-4.3M, free cash flow of $3.3M. Top institutional holders of CCRN by reported 13-F value include Boston Partners, BlackRock, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. CCRN trades on the Nasdaq exchange and files with the SEC under CIK 1141103. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CCRN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CROSS COUNTRY HEALTHCARE INC directly from SEC EDGAR. CROSS COUNTRY HEALTHCARE INC's 13F Pro composite quality score has ranged between 25 and 70 since 2021, currently 26.6 — a declining long-term trajectory across 67 quarterly and live scoring snapshots.
Revenue
Q1 2026
$241.1M
Net Income
Q1 2026
$-4.3M
Free Cash Flow
Q1 2026
$3.3M
ROIC
Q1 2026
-5.3%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-21.6% YoYNet Income
-551.6% YoYOperating Income
-400.5% YoYEPS (Diluted)
-565.9% YoYTotal Assets
-23.8% YoYTotal Debt
Op. Cash Flow
-59.8% YoYFree Cash Flow
-64.0% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.05B -21.6% | $1.34B -33.5% | $2.02B -28.0% | $2.80B +67.2% | $1.68B +100.5% | $836.4M |
| Net Income | $-94.9M -551.6% | $-14.6M -120.0% | $72.6M -61.5% | $188.5M +42.8% | $132.0M +1118.4% | $-13.0M |
| Operating Income | $-84.4M -400.5% | $-16.9M -115.0% | $112.7M -58.2% | $269.9M +93.7% | $139.3M +1620.8% | $-9.2M |
| EPS (Diluted) | $-2.93 -565.9% | $-0.44 -121.5% | $2.05 -58.6% | $4.95 +40.2% | $3.53 +1080.6% | $-0.36 |
| Total Assets | $449.0M -23.8% | $589.3M -13.5% | $681.1M -28.3% | $949.6M +29.6% | $732.8M +105.3% | $357.0M |
| Total Debt | — | — | — | $150.7M -19.0% | $185.9M +219.2% | $58.3M |
| Operating Cash Flow | $48.3M -59.8% | $120.1M -51.7% | $248.5M +85.4% | $134.1M +256.6% | $-85.6M -414.7% | $27.2M |
| Free Cash Flow | $40.1M -64.0% | $111.4M -52.5% | $234.5M +87.2% | $125.3M +235.0% | $-92.8M -510.8% | $22.6M |
Get alerted when CCRN's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for CROSS COUNTRY HEALTHCARE INC including:
Top Institutional Holders of CCRN
Boston Partners
$23.9M2,545,584 shBlackRock, Inc.
$23.6M2,507,042 shDIMENSIONAL FUND ADVISORS LP
$15.1M1,609,925 shVANGUARD CAPITAL MANAGEMENT LLC
$12.9M1,369,654 shSio Capital Management, LLC
$10.3M1,098,393 shQuinn Opportunity Partners LLC
$9.6M1,025,620 shCHARLES SCHWAB INVESTMENT MANAGEMENT INC
$8.9M952,125 shAMERICAN CENTURY COMPANIES INC
$8.9M948,128 shODDO BHF ASSET MANAGEMENT SAS
$8.8M940,000 shDana Investment Advisors, Inc.
$8.8M933,217 sh
| Fund | Value | Shares |
|---|---|---|
| Boston Partners | $23.9M | 2,545,584 |
| BlackRock, Inc. | $23.6M | 2,507,042 |
| DIMENSIONAL FUND ADVISORS LP | $15.1M | 1,609,925 |
| VANGUARD CAPITAL MANAGEMENT LLC | $12.9M | 1,369,654 |
| Sio Capital Management, LLC | $10.3M | 1,098,393 |
| Quinn Opportunity Partners LLC | $9.6M | 1,025,620 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8.9M | 952,125 |
| AMERICAN CENTURY COMPANIES INC | $8.9M | 948,128 |
| ODDO BHF ASSET MANAGEMENT SAS | $8.8M | 940,000 |
| Dana Investment Advisors, Inc. | $8.8M | 933,217 |
Companies Similar to CCRN
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Emerald Holding, Inc.
International Money Express, Inc.
Koppers Holdings Inc.
TTEC Holdings, Inc.
WABASH NATIONAL Corp
STONERIDGE INC
AVANOS MEDICAL, INC.
FOX FACTORY HOLDING CORP
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Industrials Companies
View all Industrials →Put CCRN on your watchlist
Track score changes the day CROSS COUNTRY HEALTHCARE INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CCRN a good stock to buy?
13F Pro's AI-powered analysis of CROSS COUNTRY HEALTHCARE INC (CCRN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CCRN are available on the CCRN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CCRN is classified as a small company.
Which hedge funds own CCRN?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CCRN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CROSS COUNTRY HEALTHCARE INC's investment landscape.